Methanolic extracts of bitter melon inhibit colon cancer stem cells by affecting energy homeostasis and autophagy

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Kwatra, Deep ^a   Subramaniam, Dharmalingam ^a,b   Ramamoorthy, Prabhu ^a,b   Standing, David ^a,b   Moran, Elizabeth ^a   Velayutham, Ravichandiran ^c   Mitra, Ashim ^d   Umar, Shahid ^a,b   Anant, Shrikant ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS CANCER CENTER   (United States)

^c VELS INSTITUTE OF SCIENCE   (India)

^d UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY PROTEIN 12; AUTOPHAGY PROTEIN 7; BECLIN 1; CASPASE 3; CASPASE 7; DOUBLECORTIN CALMODULIN LIKE KINASE 1; MOMORDICA CHARANTIA EXTRACT; PEPTIDES AND PROTEINS; PROTEIN; PROTEIN BCL 2; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; AUTOPHAGY; CANCER STEM CELL; CELL ACTIVITY; CELL CYCLE; CELL CYCLE ARREST; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL PROLIFERATION; CLONOGENESIS; COLON CANCER; COLONY FORMATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; G2 PHASE CELL CYCLE CHECKPOINT; HOMEOSTASIS; HUMAN; HUMAN CELL; IC 50; MOMORDICA CHARANTIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; S PHASE CELL CYCLE CHECKPOINT; UBIQUITINATION; UPREGULATION;

EID: 84875709338     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/702869     Document Type: Article

References (48)

1. Siegel R., Naishadham D., Jemal A., Cancer statistics, 2012. CA: A Cancer Journal for Clinicians 2012 62 1 10 29 10.3322/caac.20138
2. Erlanson-Albertsson C., High-fat diet not harmless-serious health risks have been surveyed. Atherosclerosis, breast and colonic cancer, depression, reduced memory, dependence. Lakartidningen 2011 108 51-52 2713 2717
3. Mandong B. M., Ngbea J. A., Cancer prevention strategies. Nigerian Medical Journal 2011 20 4 399 405
4. Goel A., Aggarwal B. B., Curcumin, the golden spice from Indian saffron, is a chemosensitizer and radiosensitizer for tumors and chemoprotector and radioprotector for normal organs. Nutrition and Cancer 2010 62 7 919 930 2-s2.0-77958011209 10.1080/01635581.2010.509835
5. Wilken R., Veena M. S., Wang M. B., Srivatsan E. S., Curcumin: a review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Molecular Cancer 2011 10 article 12 2-s2.0-79551639050 10.1186/1476-4598-10-12
6. Yin J., Zhang H., Ye J., Traditional chinese medicine in treatment of metabolic syndrome. Endocrine, Metabolic and Immune Disorders Drug Targets 2008 8 2 99 111 10.2174/187153008784534330
7. Thomasset S. C., Berry D. P., Garcea G., Marczylo T., Steward W. P., Gescher A. J., Dietary polyphenolic phytochemicals-promising cancer chemopreventive agents in humans? A review of their clinical properties. International Journal of Cancer 2007 120 3 451 458 10.1002/ijc.22419 (Pubitemid 44969013)
8. Leung L., Birtwhistle R., Kotecha J., Hannah S., Cuthbertson S., Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review. The British Journal of Nutrition 2009 102 12 1703 1708 2-s2.0-74949111350 10.1017/S0007114509992054
9. Nerurkar P. V., Lee Y. K., Motosue M., Adeli K., Nerurkar V. R., Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions. The British Journal of Nutrition 2008 100 4 751 759 2-s2.0-51749119492 10.1017/S0007114508937430
10. Nerurkar P., Ray R. B., Bitter melon: antagonist to cancer. Pharmaceutical Research 2010 27 6 1049 1053 10.1007/s11095-010-0057-2
11. Basch E., Gabardi S., Ulbricht C., Bitter melon (Momordica charantia): a review of efficacy and safety. The American Journal of Health-System Pharmacy 2003 60 4 356 359 2-s2.0-0038283005 (Pubitemid 36749034)
12. Ray R. B., Raychoudhuri A., Steele R., Nerurkar P., Bitter Melon (Momordica charantia) extract inhibits breast cancer cell proliferation by modulating cell cycle regulatory genes and promotes apoptosis. Cancer Research 2010 70 5 1925 1931 2-s2.0-77950278220 10.1158/0008-5472.CAN-09-3438
13. Nagasawa H., Watanabe K., Inatomi H., Effects of bitter melon (Momordica charantia L.) or ginger rhizome (Zingiber offifinale Rosc) on spontaneous mammary tumorigenesis in SHN mice. The American Journal of Chinese Medicine 2002 30 2-3 195 205 2-s2.0-0013149054 10.1142/S0192415X02000302 (Pubitemid 41758893)
14. Ru P., Steele R., Nerurkar P. V., Phillips N., Ray R. B., Bitter melon extract impairs prostate cancer cell-cycle progression and delays prostatic intraepithelial neoplasia in TRAMP model. Cancer Prevention Research 2011 4 2122 2130 10.1158/1940-6207.CAPR-11-0376
15. Lee-Huang S., Huang P. L., Sun Y., Chen H. C., Kung H. F., Murphy W. J., Inhibition of MDA-MB-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30. Anticancer Research 2000 20 2 653 659 (Pubitemid 30240615)
16. Xiong S. D., Yu K., Liu X. H., Yin L. H., Kirschenbaum A., Yao S., Narla G., DiFeo A., Wu J. B., Yuan Y., Ho S. M., Lam Y. W., Levine A. C., Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. International Journal of Cancer 2009 125 4 774 782 2-s2.0-67650097017 10.1002/ijc.24325
17. Jilka C., Strifler B., Fortner G. W., Hays E. F., Takemoto D. J., In vivo antitumor activity of the bitter melon (Momordica charantia). Cancer Research 1983 43 11 5151 5155 (Pubitemid 14227492)
18. Akihisa T., Higo N., Tokuda H., Ukiya M., Akazawa H., Tochigi Y., Kimura Y., Suzuki T., Nishino H., Cucurbitane-type triterpenoids from the fruits of Momordica charantia and their cancer chemopreventive effects. Journal of Natural Products 2007 70 8 1233 1239 2-s2.0-34548657973 10.1021/np068075p (Pubitemid 47401558)
19. Tsuzuki T., Tokuyama Y., Igarashi M., Miyazawa T., Tumor growth suppression by alpha-eleostearic acid, a linolenic acid isomer with a conjugated triene system, via lipid peroxidation. Carcinogenesis 2004 25 8 1417 1425 10.1093/carcin/bgh109 (Pubitemid 39162707)
20. Grossmann M. E., Mizuno N. K., Dammen M. L., Schuster T., Ray A., Cleary M. P., Eleostearic Acid inhibits breast cancer proliferation by means of an oxidation-dependent mechanism. Cancer Prevention Research 2009 2 879 886 10.1158/1940-6207.CAPR-09-0088
21. Subramaniam D., May R., Sureban S. M., Lee K. B., George R., Kuppusamy P., Ramanujam R. P., Hideg K., Dieckgraefe B. K., Houchen C. W., Anant S., Diphenyl difluoroketone: a curcumin derivative with potent in vivo anticancer activity. Cancer Research 2008 68 6 1962 1969 2-s2.0-40949108125 10.1158/0008-5472.CAN-07-6011 (Pubitemid 351416583)
22. Fujishima Y., Nishiumi S., Masuda A., Inoue J., Nguyen N. M. T., Irino Y., Komatsu M., Tanaka K., Kutsumi H., Azuma T., Yoshida M., Autophagy in the intestinal epithelium reduces endotoxin-induced inflammatory responses by inhibiting NF- B activation. Archives of Biochemistry and Biophysics 2011 506 2 223 235 2-s2.0-79151474603 10.1016/j.abb.2010.12.009
23. Comes F., Matrone A., Lastella P., Nico B., Susca F. C., Bagnulo R., Ingravallo G., Modica S., Lo Sasso G., Moschetta A., Guanti G., Simone C., A novel cell type-specific role of p38 α in the control of autophagy and cell death in colorectal cancer cells. Cell Death and Differentiation 2007 14 4 693 702 2-s2.0-33947418965 10.1038/sj.cdd.4402076 (Pubitemid 46444507)
24. Sou Y. S., Tanida I., Komatsu M., Ueno T., Kominami E., Phosphatidylserine in addition to phosphatidylethanolamine is an in vitro target of the mammalian Atg8 modifiers, LC3, GABARAP, and GATE-16. The Journal of Biological Chemistry 2006 281 6 3017 3024 2-s2.0-33645652024 10.1074/jbc.M505888200 (Pubitemid 43845910)
25. Sivridis E., Koukourakis M. I., Zois C. E., Ledaki I., Ferguson D. J. P., Harris A. L., Gatter K. C., Giatromanolaki A., LC3A-positive light microscopy detected patterns of autophagy and prognosis in operable breast carcinomas. The American Journal of Pathology 2010 176 5 2477 2489 2-s2.0-77952040472 10.2353/ajpath.2010.090049
26. Ko H., Kim Y. J., Amor E. C., Lee J. W., Kim H. C., Kim H. J., Yang H. O., Induction of autophagy by dimethyl cardamonin is associated with proliferative arrest in human colorectal carcinoma HCT116 and LOVO cells. Journal of Cellular Biochemistry 2011 112 9 2471 2479 10.1002/jcb.23171
27. He C., Levine B., The Beclin 1 interactome. Current Opinion in Cell Biology 2010 22 2 140 149 10.1016/j.ceb.2010.01.001
28. Hardie D. G., Hawley S. A., Scott J. W., AMP-activated protein kinase-development of the energy sensor concept. The Journal of Physiology 2006 574 7 15 10.1113/jphysiol.2006.108944 (Pubitemid 43905792)
29. Kim J., Kundu M., Viollet B., Guan K. L., AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nature Cell Biology 2011 13 132 141 10.1038/ncb2152
30. Fillmore C. M., Kuperwasser C., Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Research 2008 10 2, article R25 2-s2.0-48949119473 10.1186/bcr1982
31. Kanwar S. S., Yu Y., Nautiyal J., Patel B. B., Majumdar A. P., The Wnt/beta-catenin pathway regulates growth and maintenance of colonospheres. Molecular Cancer 2010 9 article 212 10.1186/1476-4598-9-212
32. Dhar A., Fogt L., Subramaniam D., Anant S., Sarkar F. H., Cancer stem cells: novel target using dietary components for prevention and treatment. Nutraceuticals and Cancer 2012 Amsterdam, The Netherlands Springer 11 38
33. Signorelli P., Ghidoni R., Resveratrol as an anticancer nutrient: molecular basis, open questions and promises. Journal of Nutritional Biochemistry 2005 16 8 449 466 2-s2.0-22844450866 10.1016/j.jnutbio.2005.01.017 (Pubitemid 41039220)
34. Yu J., Ahmedna M., Goktepe I., Effects of processing methods and extraction solvents on concentration and antioxidant activity of peanut skin phenolics. Food Chemistry 2005 90 1-2 199 206 2-s2.0-4644227429 10.1016/j.foodchem.2004.03.048 (Pubitemid 39298803)
35. Filippi-Chiela E. C., Villodre E. S., Zamin L. L., Lenz G., Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells. PLoS ONE 2011 6 6 2-s2.0-79958700761 10.1371/journal.pone.0020849 e20849
36. Li C.-J., Tsang S.-F., Tsai C.-H., Tsai H.-Y., Hsu H.-Y., Momordica charantia extract induce apoptosis in human cancer cells through caspase- and mitochondria-dependent pathways. Evidence-Based Complementary and Alternative Medicine 2012 2012 11 261971 10.1155/2012/261971
37. Shoshan M. C., Potentiation of anti-cancer treatment by modulators of energy metabolism. Current Pharmaceutical Biotechnology. In press
38. Meisse D., van de Casteele M., Beauloye C., Hainault I., Kefas B. A., Rider M. H., Foufelle F., Hue L., Sustained activation of AMP-activated protein kinase induces c-Jun N-terminal kinase activation and apoptosis in liver cells. FEBS Letters 2002 526 1-3 38 42 2-s2.0-0037189947 10.1016/S0014-5793(02)03110-1 (Pubitemid 35245688)
39. Harhaji-Trajkovic L., Vilimanovich U., Kravic-Stevovic T., Bumbasirevic V., Trajkovic V., AMPK-mediated autophagy inhibits apoptosis in cisplatin-treated tumour cells. Journal of Cellular and Molecular Medicine 2009 13 9 3644 3654 10.1111/j.1582-4934.2009.00663.x
40. Rocco A., Liguori E., Pirozzi G., Tirino V., Compare D., Franco R., Tatangelo F., Palaia R., 'Armiento FP D., Pollastrone G., Affuso A., Bottazzi E. C., Masone S., Persico G., Nardone G., CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Journal of Cellular Physiology 2012 227 6 2686 2693 10.1002/jcp.23013
41. Jordan C. T., Cancer stem cells: controversial or just misunderstood? Cell Stem Cell 2009 4 3 203 205 10.1016/j.stem.2009.02.003
42. Mori T., Kiyono T., Imabayashi H., Takeda Y., Tsuchiya K., Miyoshi S., Makino H., Matsumoto K., Saito H., Ogawa S., Sakamoto M., Hata J. I., Umezawa A., Combination of hTERT and bmi-1, E6, or E7 induces prolongation of the life span of bone marrow stromal cells from an elderly donor without affecting their neurogenic potential. Molecular and Cellular Biology 2005 25 12 5183 5195 2-s2.0-20344377968 10.1128/MCB.25.12.5183-5195.2005 (Pubitemid 40781116)
43. Huang M. Y., Wang H. M., Chang H. J., Hsiao C. P., Wang J. Y., Lin S. R., Overexpression of S100B, TM4SF4, and OLFM4 genes is correlated with liver metastasis in Taiwanese colorectal cancer patients. DNA and Cell Biology 2012 31 1 43 49 10.1089/dna.2011.1264
44. Tatrai P., Szepesi A., Matula Z., Szigeti A., Buchan G., Madi A., Uher F., Nemet K., Combined introduction of Bmi-1 and hTERT immortalizes human adipose tissue-derived stromal cells with low risk of transformation. Biochemical and Biophysical Research Communications 2012 422 1 28 35 10.1016/j.bbrc.2012.04.088
45. Kemper K., Grandela C., Medema J. P., Molecular identification and targeting of colorectal cancer stem cells. Oncotarget 2010 1 6 387 395 2-s2.0-79957467315
46. May R., Riehl T. E., Hunt C., Sureban S. M., Anant S., Houchen C. W., Identification of a novel putative gastrointestinal stem cell and adenoma stem cell marker, doublecortin and CaM kinase-like-1, following radiation injury and in adenomatous polyposis coli/multiple intestinal neoplasia mice. Stem Cells 2008 26 3 630 637 2-s2.0-43049128928 10.1634/stemcells.2007-0621
47. Barker N., van Es J. H., Kuipers J., Kujala P., van den Born M., Cozijnsen M., Haegebarth A., Korving J., Begthel H., Peters P. J., Clevers H., Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 2007 449 7165 1003 1007 2-s2.0-35548974423 10.1038/nature06196 (Pubitemid 350014593)
48. Boman B. M., Huang E., Human colon cancer stem cells: a new paradigm in gastrointestinal oncology. Journal of Clinical Oncology 2008 26 17 2828 2838 10.1200/JCO.2008.17.6941